Literature DB >> 16629644

Expression pattern of angiogenic factors and prognosis after hepatic resection in hepatocellular carcinoma: importance of angiopoietin-2 and hypoxia-induced factor-1 alpha.

Hiroshi Wada1, Hiroaki Nagano, Hirofumi Yamamoto, Yubo Yang, Motoi Kondo, Hideo Ota, Masato Nakamura, Shinichi Yoshioka, Hitoshi Kato, Bazarragchaa Damdinsuren, Di Tang, Sigeru Marubashi, Atsushi Miyamoto, Yutaka Takeda, Koji Umeshita, Shoji Nakamori, Masato Sakon, Keizo Dono, Kenichi Wakasa, Morito Monden.   

Abstract

BACKGROUND: Hepatocellular carcinoma (HCC) is a hypervascular tumor and angiogenesis plays an important role in its progression. Angiogenesis is regulated by a balance between pro and antiangiogenic molecules. The aim of this study was to investigate the expressions of angiogenic factors and elucidate their roles in angiogenesis in HCC.
METHODS: We investigated immunohistochemical expression of vascular endothelial growth factor (VEGF), angiopoietins (Ang-1 and Ang-2), hypoxia-induced factor-1alpha (HIF-1alpha) and thrombospondin-1 (TSP-1) in 60 specimens of surgically resected HCC. We investigated the relationship between their expressions and clinicopathological factors or prognosis.
RESULTS: Ang-2 staining had a significant correlation with the grade of differentiation of HCC cells (P=0.0082). VEGF and Ang-2 expression correlated positively with microvessel density (MVD) (P=0.0061 and 0.0374, respectively). MVD of well-differentiated HCC were significantly lower than those of moderately and poorly differentiated HCC. The disease-free survival time of patients with high Ang-2 and/or HIF-1alpha expression was significantly shorter than that of the low expression group (P=0.0278 and 0.0374, respectively).
CONCLUSION: Our study showed that the expression of VEGF and Ang-2 correlated with MVD. Strong Ang-2 expression and/or high nuclear expression of HIF-1alpha is a significant predictive factor for recurrence after curative resection in HCC patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16629644     DOI: 10.1111/j.1478-3231.2006.01243.x

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  45 in total

Review 1.  Predictive biomarkers of antiangiogenic therapy for advanced hepatocellular carcinoma: where are we?

Authors:  Yu-Yun Shao; Chih-Hung Hsu; Ann-Lii Cheng
Journal:  Liver Cancer       Date:  2013-04       Impact factor: 11.740

2.  Edmondson-Steiner grading increases the predictive efficiency of TNM staging for long-term survival of patients with hepatocellular carcinoma after curative resection.

Authors:  Li Zhou; Jing-An Rui; Da-Xiong Ye; Shao-Bin Wang; Shu-Guang Chen; Qiang Qu
Journal:  World J Surg       Date:  2008-08       Impact factor: 3.352

3.  Evaluation of microvessel density of hepatocellular carcinoma and comparison with benign lesions of liver: an immunohistochemical study.

Authors:  S Amoueian; A Attaranzadeh; F Pouralborzi; M Tarhini; M Montazer
Journal:  Iran Red Crescent Med J       Date:  2012-02-01       Impact factor: 0.611

4.  A Phase I dose-escalation, pharmacokinetics and food-effect study of oral donafenib in patients with advanced solid tumours.

Authors:  Xiaoyu Li; Meng Qiu; Li Zheng; ShengJun Wang; Hong Zhu; Bi Feng
Journal:  Cancer Chemother Pharmacol       Date:  2020-02-01       Impact factor: 3.333

Review 5.  Hypoxic and highly angiogenic non-tumor tissues surrounding hepatocellular carcinoma: the 'niche' of endothelial progenitor cells.

Authors:  De-Cai Yu; Jun Chen; Yi-Tao Ding
Journal:  Int J Mol Sci       Date:  2010-08-09       Impact factor: 5.923

6.  Diagnostic and prognostic significance of peroxiredoxin 1 expression in human hepatocellular carcinoma.

Authors:  Qi-Kai Sun; Jian-Yu Zhu; Wei Wang; Yang Lv; Hang-Cheng Zhou; Ji-Hai Yu; Ge-Liang Xu; Jin-Liang Ma; Wen Zhong; Wei-Dong Jia
Journal:  Med Oncol       Date:  2013-12-03       Impact factor: 3.064

7.  Prognostic significance of vascular endothelial growth factor expression in hepatocellular carcinoma tissue: a meta-analysis.

Authors:  Ping Zhan; Qian Qian; Li-Ke Yu
Journal:  Hepatobiliary Surg Nutr       Date:  2013-06       Impact factor: 7.293

8.  New pharmacological developments in the treatment of hepatocellular cancer.

Authors:  Niraj J Gusani; Yixing Jiang; Eric T Kimchi; Kevin F Staveley-O'Carroll; Hua Cheng; Jaffer A Ajani
Journal:  Drugs       Date:  2009       Impact factor: 9.546

Review 9.  Role of thrombospondin 1 in liver diseases.

Authors:  Yanzhang Li; Courtney P Turpin; Shuxia Wang
Journal:  Hepatol Res       Date:  2016-08-30       Impact factor: 4.288

10.  Combination of interferon-alpha and 5-fluorouracil inhibits endothelial cell growth directly and by regulation of angiogenic factors released by tumor cells.

Authors:  Hiroshi Wada; Hiroaki Nagano; Hirofumi Yamamoto; Takehiro Noda; Masahiro Murakami; Shogo Kobayashi; Shigeru Marubashi; Hidetoshi Eguchi; Yutaka Takeda; Masahiro Tanemura; Koji Umeshita; Yuichiro Doki; Masaki Mori
Journal:  BMC Cancer       Date:  2009-10-12       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.